Amid the uncertainty surrounding eligibility for and access to the latest Covid-19 vaccine, a new study has found that a ...

The over-the-counter antihistamine azelastine works against a range of respiratory infections, including the flu and RSV, ...

In addition to showing a marked reduction in coronavirus infections, the azelastine group also displayed fewer symptomatic ...

An over-the-counter nasal spray antihistamine reduced rates of COVID-19 infections and common colds in a midstage trial, ...

Azelastine nasal spray was associated with a reduced risk for SARS-CoV-2 infection, according to the results of a phase 2 ...

The US Food and Drug Administration (FDA) has approved the first intranasal diuretic for heart, liver and kidney disease ...

A single dose of neffy epinephrine nasal spray resulted in successful treatment of anaphylaxis symptoms during oral food ...

The U.S. regulator has signed off on Corstasis Therapeutics’ Enbumyst to relieve the edema associated with congestive heart ...

Researchers have found in a new study that azelastine nasal spray may help reduce the risk of SARS-CoV-2 infection.

A phase 2 study shows that azelastine nasal spray lowered coronavirus infection rates to 2.2% compared to 6.7%, researchers ...

This nasal spray has been available over the counter for decades now, under a variety of brand names, in over 70 countries.

This year also brings something new: The FDA has approved a self-administered version of a nasal spray you can use at home. It arrives temperature-controlled, with two premeasured doses, one for each ...